nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—Vismodegib—Sulfasalazine—ulcerative colitis	0.469	1	CrCrCtD
Tolvaptan—ABCB1—ulcerative colitis	0.223	1	CbGaD
Tolvaptan—CYP3A4—Budesonide—ulcerative colitis	0.0317	0.147	CbGbCtD
Tolvaptan—ABCB1—Methylprednisolone—ulcerative colitis	0.0236	0.11	CbGbCtD
Tolvaptan—ABCB1—Betamethasone—ulcerative colitis	0.0154	0.0713	CbGbCtD
Tolvaptan—ABCB1—Prednisolone—ulcerative colitis	0.0151	0.0704	CbGbCtD
Tolvaptan—ABCB1—Hydrocortisone—ulcerative colitis	0.0144	0.0667	CbGbCtD
Tolvaptan—ABCB1—Prednisone—ulcerative colitis	0.0143	0.0665	CbGbCtD
Tolvaptan—CYP3A4—Methylprednisolone—ulcerative colitis	0.0141	0.0657	CbGbCtD
Tolvaptan—CYP3A4—Nicotine—ulcerative colitis	0.0138	0.0641	CbGbCtD
Tolvaptan—CYP3A4—Cholecalciferol—ulcerative colitis	0.0124	0.0575	CbGbCtD
Tolvaptan—CYP3A4—Triamcinolone—ulcerative colitis	0.0107	0.0498	CbGbCtD
Tolvaptan—CYP3A4—Betamethasone—ulcerative colitis	0.0092	0.0427	CbGbCtD
Tolvaptan—CYP3A4—Prednisolone—ulcerative colitis	0.00907	0.0422	CbGbCtD
Tolvaptan—ABCB1—Dexamethasone—ulcerative colitis	0.00893	0.0415	CbGbCtD
Tolvaptan—CYP3A4—Hydrocortisone—ulcerative colitis	0.0086	0.04	CbGbCtD
Tolvaptan—CYP3A4—Prednisone—ulcerative colitis	0.00857	0.0398	CbGbCtD
Tolvaptan—CYP3A4—Dexamethasone—ulcerative colitis	0.00535	0.0249	CbGbCtD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.00101	0.0302	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.001	0.03	CbGpPWpGaD
Tolvaptan—Zafirlukast—PTGS1—ulcerative colitis	0.000989	0.543	CrCbGaD
Tolvaptan—AVPR1A—Peptide GPCRs—CXCR1—ulcerative colitis	0.000985	0.0294	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide GPCRs—CXCR1—ulcerative colitis	0.000978	0.0292	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide GPCRs—CXCR2—ulcerative colitis	0.000771	0.023	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide GPCRs—CXCR2—ulcerative colitis	0.000765	0.0228	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide GPCRs—CCR6—ulcerative colitis	0.000725	0.0216	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide GPCRs—CCR6—ulcerative colitis	0.000719	0.0215	CbGpPWpGaD
Tolvaptan—AVPR2—Arf6 trafficking events—ADRB2—ulcerative colitis	0.00069	0.0206	CbGpPWpGaD
Tolvaptan—AVPR2—Vasopressin regulates renal water homeostasis via Aquaporins—ADCY5—ulcerative colitis	0.000629	0.0188	CbGpPWpGaD
Tolvaptan—AVPR2—Aquaporin-mediated transport—ADCY5—ulcerative colitis	0.000549	0.0164	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CXCR1—ulcerative colitis	0.000463	0.0138	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CXCR1—ulcerative colitis	0.00046	0.0137	CbGpPWpGaD
Tolvaptan—Vismodegib—ALB—ulcerative colitis	0.000427	0.234	CrCbGaD
Tolvaptan—ABCB1—Allograft Rejection—MICA—ulcerative colitis	0.000419	0.0125	CbGpPWpGaD
Tolvaptan—AVPR2—G alpha (s) signalling events—PTGER4—ulcerative colitis	0.000419	0.0125	CbGpPWpGaD
Tolvaptan—AVPR2—Arf6 trafficking events—CDH1—ulcerative colitis	0.000417	0.0124	CbGpPWpGaD
Tolvaptan—Vismodegib—ABCB1—ulcerative colitis	0.000407	0.223	CrCbGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.000407	0.0121	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.000404	0.012	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000384	0.0115	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000363	0.0108	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.000362	0.0108	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.00036	0.0107	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.00036	0.0107	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.000341	0.0102	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.000338	0.0101	CbGpPWpGaD
Tolvaptan—AVPR2—G alpha (s) signalling events—ADRB2—ulcerative colitis	0.000318	0.00947	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000311	0.00927	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000308	0.0092	CbGpPWpGaD
Tolvaptan—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000304	0.00906	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000284	0.00846	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000282	0.0084	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000278	0.0083	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.000275	0.00819	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000273	0.00814	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.000273	0.00813	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000271	0.00808	CbGpPWpGaD
Tolvaptan—AVPR2—G alpha (s) signalling events—ADCY5—ulcerative colitis	0.00027	0.00804	CbGpPWpGaD
Tolvaptan—ABCB1—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000269	0.00803	CbGpPWpGaD
Tolvaptan—Cardiac disorder—Budesonide—ulcerative colitis	0.000267	0.00464	CcSEcCtD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000267	0.00796	CbGpPWpGaD
Tolvaptan—Decreased appetite—Mercaptopurine—ulcerative colitis	0.000267	0.00463	CcSEcCtD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000265	0.0079	CbGpPWpGaD
Tolvaptan—Gastrointestinal disorder—Mercaptopurine—ulcerative colitis	0.000265	0.0046	CcSEcCtD
Tolvaptan—Angiopathy—Budesonide—ulcerative colitis	0.000261	0.00454	CcSEcCtD
Tolvaptan—Immune system disorder—Budesonide—ulcerative colitis	0.00026	0.00452	CcSEcCtD
Tolvaptan—Mediastinal disorder—Budesonide—ulcerative colitis	0.00026	0.00451	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.000257	0.00446	CcSEcCtD
Tolvaptan—Renal failure—Mesalazine—ulcerative colitis	0.000257	0.00445	CcSEcCtD
Tolvaptan—Ecchymosis—Betamethasone—ulcerative colitis	0.000256	0.00445	CcSEcCtD
Tolvaptan—Ecchymosis—Dexamethasone—ulcerative colitis	0.000256	0.00445	CcSEcCtD
Tolvaptan—Constipation—Nicotine—ulcerative colitis	0.000254	0.00441	CcSEcCtD
Tolvaptan—Malnutrition—Budesonide—ulcerative colitis	0.000251	0.00435	CcSEcCtD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000249	0.00742	CbGpPWpGaD
Tolvaptan—Dysgeusia—Budesonide—ulcerative colitis	0.000246	0.00426	CcSEcCtD
Tolvaptan—Feeling abnormal—Nicotine—ulcerative colitis	0.000245	0.00425	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000243	0.00725	CbGpPWpGaD
Tolvaptan—Body temperature increased—Mercaptopurine—ulcerative colitis	0.000242	0.00421	CcSEcCtD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000241	0.0072	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CXCR1—ulcerative colitis	0.000237	0.00706	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CXCR1—ulcerative colitis	0.000235	0.00701	CbGpPWpGaD
Tolvaptan—Body temperature increased—Nicotine—ulcerative colitis	0.000235	0.00408	CcSEcCtD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000235	0.00701	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000233	0.00696	CbGpPWpGaD
Tolvaptan—Ill-defined disorder—Budesonide—ulcerative colitis	0.000233	0.00404	CcSEcCtD
Tolvaptan—Immune system disorder—Azathioprine—ulcerative colitis	0.000232	0.00403	CcSEcCtD
Tolvaptan—Mediastinal disorder—Azathioprine—ulcerative colitis	0.000232	0.00403	CcSEcCtD
Tolvaptan—Urinary tract disorder—Mesalazine—ulcerative colitis	0.000231	0.00402	CcSEcCtD
Tolvaptan—Connective tissue disorder—Mesalazine—ulcerative colitis	0.00023	0.004	CcSEcCtD
Tolvaptan—Urethral disorder—Mesalazine—ulcerative colitis	0.00023	0.00399	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000229	0.00682	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000227	0.00677	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000227	0.00676	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000227	0.00676	CbGpPWpGaD
Tolvaptan—Malaise—Budesonide—ulcerative colitis	0.000226	0.00393	CcSEcCtD
Tolvaptan—Hypersensitivity—Mercaptopurine—ulcerative colitis	0.000226	0.00392	CcSEcCtD
Tolvaptan—Syncope—Budesonide—ulcerative colitis	0.000225	0.00391	CcSEcCtD
Tolvaptan—Ecchymosis—Prednisone—ulcerative colitis	0.000223	0.00388	CcSEcCtD
Tolvaptan—Loss of consciousness—Budesonide—ulcerative colitis	0.00022	0.00383	CcSEcCtD
Tolvaptan—Hypersensitivity—Nicotine—ulcerative colitis	0.000219	0.0038	CcSEcCtD
Tolvaptan—Cardiac disorder—Mesalazine—ulcerative colitis	0.000217	0.00378	CcSEcCtD
Tolvaptan—Asthenia—Nicotine—ulcerative colitis	0.000213	0.0037	CcSEcCtD
Tolvaptan—Angiopathy—Mesalazine—ulcerative colitis	0.000213	0.00369	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Hydrocortisone—ulcerative colitis	0.000212	0.00369	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.000212	0.00368	CcSEcCtD
Tolvaptan—Immune system disorder—Mesalazine—ulcerative colitis	0.000212	0.00367	CcSEcCtD
Tolvaptan—Mediastinal disorder—Mesalazine—ulcerative colitis	0.000211	0.00367	CcSEcCtD
Tolvaptan—Discomfort—Budesonide—ulcerative colitis	0.000211	0.00366	CcSEcCtD
Tolvaptan—Pruritus—Nicotine—ulcerative colitis	0.00021	0.00365	CcSEcCtD
Tolvaptan—Diarrhoea—Mercaptopurine—ulcerative colitis	0.00021	0.00364	CcSEcCtD
Tolvaptan—Dry mouth—Budesonide—ulcerative colitis	0.000209	0.00363	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—CCL20—ulcerative colitis	0.000208	0.0062	CbGpPWpGaD
Tolvaptan—Ill-defined disorder—Azathioprine—ulcerative colitis	0.000208	0.00361	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—CCL20—ulcerative colitis	0.000206	0.00615	CbGpPWpGaD
Tolvaptan—Anaphylactic shock—Budesonide—ulcerative colitis	0.000205	0.00355	CcSEcCtD
Tolvaptan—Breast disorder—Methylprednisolone—ulcerative colitis	0.000204	0.00355	CcSEcCtD
Tolvaptan—Diarrhoea—Nicotine—ulcerative colitis	0.000203	0.00353	CcSEcCtD
Tolvaptan—Malaise—Azathioprine—ulcerative colitis	0.000202	0.00351	CcSEcCtD
Tolvaptan—Shock—Budesonide—ulcerative colitis	0.000201	0.0035	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000201	0.006	CbGpPWpGaD
Tolvaptan—Nervous system disorder—Budesonide—ulcerative colitis	0.000201	0.00349	CcSEcCtD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.0002	0.00596	CbGpPWpGaD
Tolvaptan—Dysgeusia—Mesalazine—ulcerative colitis	0.0002	0.00347	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Methylprednisolone—ulcerative colitis	0.0002	0.00346	CcSEcCtD
Tolvaptan—Skin disorder—Budesonide—ulcerative colitis	0.000199	0.00345	CcSEcCtD
Tolvaptan—Dizziness—Nicotine—ulcerative colitis	0.000197	0.00341	CcSEcCtD
Tolvaptan—Anorexia—Budesonide—ulcerative colitis	0.000195	0.00339	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000189	0.00329	CcSEcCtD
Tolvaptan—Ill-defined disorder—Mesalazine—ulcerative colitis	0.000189	0.00329	CcSEcCtD
Tolvaptan—Discomfort—Azathioprine—ulcerative colitis	0.000188	0.00327	CcSEcCtD
Tolvaptan—Headache—Nicotine—ulcerative colitis	0.000186	0.00323	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—CXCR2—ulcerative colitis	0.000185	0.00552	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000184	0.0055	CbGpPWpGaD
Tolvaptan—Malaise—Mesalazine—ulcerative colitis	0.000184	0.00319	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—CXCR2—ulcerative colitis	0.000184	0.00548	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000183	0.00546	CbGpPWpGaD
Tolvaptan—Syncope—Mesalazine—ulcerative colitis	0.000183	0.00318	CcSEcCtD
Tolvaptan—Nausea—Mercaptopurine—ulcerative colitis	0.000182	0.00316	CcSEcCtD
Tolvaptan—Loss of consciousness—Mesalazine—ulcerative colitis	0.000179	0.00311	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Prednisone—ulcerative colitis	0.000179	0.00311	CcSEcCtD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000178	0.00531	CbGpPWpGaD
Tolvaptan—Decreased appetite—Budesonide—ulcerative colitis	0.000178	0.00309	CcSEcCtD
Tolvaptan—Skin disorder—Azathioprine—ulcerative colitis	0.000177	0.00308	CcSEcCtD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000177	0.00527	CbGpPWpGaD
Tolvaptan—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000177	0.00307	CcSEcCtD
Tolvaptan—Nausea—Nicotine—ulcerative colitis	0.000177	0.00307	CcSEcCtD
Tolvaptan—Constipation—Budesonide—ulcerative colitis	0.000175	0.00304	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—CCR6—ulcerative colitis	0.000174	0.00519	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CCR6—ulcerative colitis	0.000173	0.00515	CbGpPWpGaD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000172	0.00299	CcSEcCtD
Tolvaptan—Discomfort—Mesalazine—ulcerative colitis	0.000172	0.00298	CcSEcCtD
Tolvaptan—Dry mouth—Mesalazine—ulcerative colitis	0.00017	0.00295	CcSEcCtD
Tolvaptan—Feeling abnormal—Budesonide—ulcerative colitis	0.000169	0.00293	CcSEcCtD
Tolvaptan—Anaphylactic shock—Mesalazine—ulcerative colitis	0.000166	0.00289	CcSEcCtD
Tolvaptan—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000166	0.00496	CbGpPWpGaD
Tolvaptan—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000166	0.00495	CbGpPWpGaD
Tolvaptan—Shock—Mesalazine—ulcerative colitis	0.000164	0.00284	CcSEcCtD
Tolvaptan—Connective tissue disorder—Hydrocortisone—ulcerative colitis	0.000164	0.00284	CcSEcCtD
Tolvaptan—Nervous system disorder—Mesalazine—ulcerative colitis	0.000163	0.00283	CcSEcCtD
Tolvaptan—Body temperature increased—Budesonide—ulcerative colitis	0.000162	0.00281	CcSEcCtD
Tolvaptan—Skin disorder—Mesalazine—ulcerative colitis	0.000162	0.00281	CcSEcCtD
Tolvaptan—Hyperglycaemia—Dexamethasone—ulcerative colitis	0.00016	0.00279	CcSEcCtD
Tolvaptan—Hyperglycaemia—Betamethasone—ulcerative colitis	0.00016	0.00279	CcSEcCtD
Tolvaptan—Anorexia—Mesalazine—ulcerative colitis	0.000159	0.00275	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Prednisone—ulcerative colitis	0.000158	0.00274	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000158	0.00274	CcSEcCtD
Tolvaptan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000155	0.00461	CbGpPWpGaD
Tolvaptan—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.000154	0.00267	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—PTGER4—ulcerative colitis	0.000153	0.00457	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000153	0.00455	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—PTGER4—ulcerative colitis	0.000152	0.00454	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000151	0.00452	CbGpPWpGaD
Tolvaptan—Hypersensitivity—Budesonide—ulcerative colitis	0.000151	0.00262	CcSEcCtD
Tolvaptan—Feeling abnormal—Azathioprine—ulcerative colitis	0.000151	0.00261	CcSEcCtD
Tolvaptan—Immune system disorder—Hydrocortisone—ulcerative colitis	0.00015	0.00261	CcSEcCtD
Tolvaptan—Asthenia—Budesonide—ulcerative colitis	0.000147	0.00255	CcSEcCtD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	0.000146	0.00436	CbGpPWpGaD
Tolvaptan—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.000145	0.00252	CcSEcCtD
Tolvaptan—Malnutrition—Hydrocortisone—ulcerative colitis	0.000145	0.00252	CcSEcCtD
Tolvaptan—Pruritus—Budesonide—ulcerative colitis	0.000145	0.00251	CcSEcCtD
Tolvaptan—Decreased appetite—Mesalazine—ulcerative colitis	0.000145	0.00251	CcSEcCtD
Tolvaptan—Body temperature increased—Azathioprine—ulcerative colitis	0.000144	0.00251	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000144	0.0025	CcSEcCtD
Tolvaptan—Constipation—Mesalazine—ulcerative colitis	0.000142	0.00247	CcSEcCtD
Tolvaptan—Angiopathy—Methylprednisolone—ulcerative colitis	0.000142	0.00247	CcSEcCtD
Tolvaptan—Immune system disorder—Methylprednisolone—ulcerative colitis	0.000141	0.00245	CcSEcCtD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000141	0.00421	CbGpPWpGaD
Tolvaptan—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000141	0.00245	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—GHRL—ulcerative colitis	0.00014	0.00419	CbGpPWpGaD
Tolvaptan—Diarrhoea—Budesonide—ulcerative colitis	0.00014	0.00243	CcSEcCtD
Tolvaptan—Hyperglycaemia—Prednisone—ulcerative colitis	0.00014	0.00243	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—GHRL—ulcerative colitis	0.000139	0.00416	CbGpPWpGaD
Tolvaptan—Ill-defined disorder—Prednisolone—ulcerative colitis	0.000138	0.00239	CcSEcCtD
Tolvaptan—Feeling abnormal—Mesalazine—ulcerative colitis	0.000137	0.00238	CcSEcCtD
Tolvaptan—Malnutrition—Methylprednisolone—ulcerative colitis	0.000136	0.00237	CcSEcCtD
Tolvaptan—Dizziness—Budesonide—ulcerative colitis	0.000135	0.00235	CcSEcCtD
Tolvaptan—Hypersensitivity—Azathioprine—ulcerative colitis	0.000135	0.00234	CcSEcCtD
Tolvaptan—Ill-defined disorder—Hydrocortisone—ulcerative colitis	0.000135	0.00234	CcSEcCtD
Tolvaptan—Malaise—Prednisolone—ulcerative colitis	0.000134	0.00233	CcSEcCtD
Tolvaptan—Dysgeusia—Triamcinolone—ulcerative colitis	0.000134	0.00232	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000134	0.00399	CbGpPWpGaD
Tolvaptan—Syncope—Prednisolone—ulcerative colitis	0.000133	0.00231	CcSEcCtD
Tolvaptan—AVPR2—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000133	0.00396	CbGpPWpGaD
Tolvaptan—Body temperature increased—Mesalazine—ulcerative colitis	0.000132	0.00228	CcSEcCtD
Tolvaptan—Malaise—Hydrocortisone—ulcerative colitis	0.000131	0.00227	CcSEcCtD
Tolvaptan—Loss of consciousness—Prednisolone—ulcerative colitis	0.000131	0.00227	CcSEcCtD
Tolvaptan—Syncope—Hydrocortisone—ulcerative colitis	0.00013	0.00226	CcSEcCtD
Tolvaptan—Angiopathy—Dexamethasone—ulcerative colitis	0.000129	0.00224	CcSEcCtD
Tolvaptan—Angiopathy—Betamethasone—ulcerative colitis	0.000129	0.00224	CcSEcCtD
Tolvaptan—Headache—Budesonide—ulcerative colitis	0.000128	0.00223	CcSEcCtD
Tolvaptan—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000127	0.00221	CcSEcCtD
Tolvaptan—Ill-defined disorder—Triamcinolone—ulcerative colitis	0.000127	0.0022	CcSEcCtD
Tolvaptan—Ill-defined disorder—Methylprednisolone—ulcerative colitis	0.000126	0.0022	CcSEcCtD
Tolvaptan—Diarrhoea—Azathioprine—ulcerative colitis	0.000125	0.00217	CcSEcCtD
Tolvaptan—Discomfort—Prednisolone—ulcerative colitis	0.000125	0.00217	CcSEcCtD
Tolvaptan—Malaise—Triamcinolone—ulcerative colitis	0.000123	0.00214	CcSEcCtD
Tolvaptan—Malaise—Methylprednisolone—ulcerative colitis	0.000123	0.00213	CcSEcCtD
Tolvaptan—Hypersensitivity—Mesalazine—ulcerative colitis	0.000123	0.00213	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000123	0.00213	CcSEcCtD
Tolvaptan—Syncope—Triamcinolone—ulcerative colitis	0.000122	0.00213	CcSEcCtD
Tolvaptan—Syncope—Methylprednisolone—ulcerative colitis	0.000122	0.00212	CcSEcCtD
Tolvaptan—Discomfort—Hydrocortisone—ulcerative colitis	0.000122	0.00212	CcSEcCtD
Tolvaptan—Connective tissue disorder—Prednisone—ulcerative colitis	0.000122	0.00212	CcSEcCtD
Tolvaptan—Nausea—Budesonide—ulcerative colitis	0.000122	0.00211	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—CXCR1—ulcerative colitis	0.000121	0.00362	CbGpPWpGaD
Tolvaptan—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000121	0.0021	CcSEcCtD
Tolvaptan—Dizziness—Azathioprine—ulcerative colitis	0.000121	0.0021	CcSEcCtD
Tolvaptan—AVPR2—Signaling by GPCR—CXCR1—ulcerative colitis	0.000121	0.0036	CbGpPWpGaD
Tolvaptan—Loss of consciousness—Triamcinolone—ulcerative colitis	0.00012	0.00208	CcSEcCtD
Tolvaptan—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.00012	0.00208	CcSEcCtD
Tolvaptan—Asthenia—Mesalazine—ulcerative colitis	0.000119	0.00207	CcSEcCtD
Tolvaptan—Shock—Prednisolone—ulcerative colitis	0.000119	0.00207	CcSEcCtD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000119	0.00355	CbGpPWpGaD
Tolvaptan—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000118	0.00206	CcSEcCtD
Tolvaptan—Pruritus—Mesalazine—ulcerative colitis	0.000118	0.00204	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—CCL20—ulcerative colitis	0.000117	0.0035	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CCL20—ulcerative colitis	0.000117	0.00348	CbGpPWpGaD
Tolvaptan—Shock—Hydrocortisone—ulcerative colitis	0.000116	0.00202	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—ADRB2—ulcerative colitis	0.000116	0.00346	CbGpPWpGaD
Tolvaptan—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000116	0.00202	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—ADRB2—ulcerative colitis	0.000115	0.00344	CbGpPWpGaD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000115	0.002	CcSEcCtD
Tolvaptan—Skin disorder—Hydrocortisone—ulcerative colitis	0.000115	0.002	CcSEcCtD
Tolvaptan—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000115	0.002	CcSEcCtD
Tolvaptan—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000115	0.002	CcSEcCtD
Tolvaptan—Discomfort—Triamcinolone—ulcerative colitis	0.000115	0.00199	CcSEcCtD
Tolvaptan—Discomfort—Methylprednisolone—ulcerative colitis	0.000115	0.00199	CcSEcCtD
Tolvaptan—Headache—Azathioprine—ulcerative colitis	0.000114	0.00199	CcSEcCtD
Tolvaptan—Diarrhoea—Mesalazine—ulcerative colitis	0.000114	0.00198	CcSEcCtD
Tolvaptan—Dry mouth—Triamcinolone—ulcerative colitis	0.000114	0.00197	CcSEcCtD
Tolvaptan—Anorexia—Hydrocortisone—ulcerative colitis	0.000113	0.00196	CcSEcCtD
Tolvaptan—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	0.000113	0.00336	CbGpPWpGaD
Tolvaptan—Angiopathy—Prednisone—ulcerative colitis	0.000112	0.00195	CcSEcCtD
Tolvaptan—Immune system disorder—Prednisone—ulcerative colitis	0.000112	0.00194	CcSEcCtD
Tolvaptan—Malaise—Dexamethasone—ulcerative colitis	0.000112	0.00194	CcSEcCtD
Tolvaptan—Malaise—Betamethasone—ulcerative colitis	0.000112	0.00194	CcSEcCtD
Tolvaptan—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000111	0.00194	CcSEcCtD
Tolvaptan—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000111	0.00193	CcSEcCtD
Tolvaptan—Syncope—Betamethasone—ulcerative colitis	0.000111	0.00193	CcSEcCtD
Tolvaptan—Syncope—Dexamethasone—ulcerative colitis	0.000111	0.00193	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—GNA12—ulcerative colitis	0.00011	0.00329	CbGpPWpGaD
Tolvaptan—Dizziness—Mesalazine—ulcerative colitis	0.00011	0.00191	CcSEcCtD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.00011	0.00328	CbGpPWpGaD
Tolvaptan—Shock—Triamcinolone—ulcerative colitis	0.00011	0.0019	CcSEcCtD
Tolvaptan—AVPR2—GPCR downstream signaling—GNA12—ulcerative colitis	0.00011	0.00327	CbGpPWpGaD
Tolvaptan—Shock—Methylprednisolone—ulcerative colitis	0.000109	0.0019	CcSEcCtD
Tolvaptan—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000109	0.00189	CcSEcCtD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.000109	0.00325	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000109	0.00325	CbGpPWpGaD
Tolvaptan—Loss of consciousness—Betamethasone—ulcerative colitis	0.000109	0.00189	CcSEcCtD
Tolvaptan—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000109	0.00189	CcSEcCtD
Tolvaptan—Nausea—Azathioprine—ulcerative colitis	0.000109	0.00188	CcSEcCtD
Tolvaptan—Skin disorder—Methylprednisolone—ulcerative colitis	0.000108	0.00188	CcSEcCtD
Tolvaptan—Malnutrition—Prednisone—ulcerative colitis	0.000108	0.00187	CcSEcCtD
Tolvaptan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000108	0.00322	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCL20—ulcerative colitis	0.000107	0.00318	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCL20—ulcerative colitis	0.000106	0.00316	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	0.000105	0.00313	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000105	0.00312	CbGpPWpGaD
Tolvaptan—Headache—Mesalazine—ulcerative colitis	0.000104	0.00181	CcSEcCtD
Tolvaptan—Discomfort—Dexamethasone—ulcerative colitis	0.000104	0.00181	CcSEcCtD
Tolvaptan—Discomfort—Betamethasone—ulcerative colitis	0.000104	0.00181	CcSEcCtD
Tolvaptan—AVPR2—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000104	0.0031	CbGpPWpGaD
Tolvaptan—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000103	0.00179	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000102	0.00177	CcSEcCtD
Tolvaptan—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000101	0.00176	CcSEcCtD
Tolvaptan—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000101	0.00176	CcSEcCtD
Tolvaptan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.0001	0.00299	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—GNA12—ulcerative colitis	0.0001	0.00299	CbGpPWpGaD
Tolvaptan—Ill-defined disorder—Prednisone—ulcerative colitis	0.0001	0.00174	CcSEcCtD
Tolvaptan—Feeling abnormal—Prednisolone—ulcerative colitis	9.99e-05	0.00173	CcSEcCtD
Tolvaptan—AVPR2—Signaling by GPCR—GNA12—ulcerative colitis	9.95e-05	0.00297	CbGpPWpGaD
Tolvaptan—Shock—Betamethasone—ulcerative colitis	9.95e-05	0.00173	CcSEcCtD
Tolvaptan—Shock—Dexamethasone—ulcerative colitis	9.95e-05	0.00173	CcSEcCtD
Tolvaptan—Nervous system disorder—Dexamethasone—ulcerative colitis	9.92e-05	0.00172	CcSEcCtD
Tolvaptan—Nervous system disorder—Betamethasone—ulcerative colitis	9.92e-05	0.00172	CcSEcCtD
Tolvaptan—Nausea—Mesalazine—ulcerative colitis	9.89e-05	0.00172	CcSEcCtD
Tolvaptan—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	9.86e-05	0.00294	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CCR6—ulcerative colitis	9.84e-05	0.00293	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CCR6—ulcerative colitis	9.77e-05	0.00291	CbGpPWpGaD
Tolvaptan—Feeling abnormal—Hydrocortisone—ulcerative colitis	9.75e-05	0.00169	CcSEcCtD
Tolvaptan—Malaise—Prednisone—ulcerative colitis	9.73e-05	0.00169	CcSEcCtD
Tolvaptan—Syncope—Prednisone—ulcerative colitis	9.68e-05	0.00168	CcSEcCtD
Tolvaptan—Anorexia—Betamethasone—ulcerative colitis	9.64e-05	0.00167	CcSEcCtD
Tolvaptan—Anorexia—Dexamethasone—ulcerative colitis	9.64e-05	0.00167	CcSEcCtD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	9.55e-05	0.00285	CbGpPWpGaD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	9.53e-05	0.00284	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CXCR2—ulcerative colitis	9.5e-05	0.00283	CbGpPWpGaD
Tolvaptan—Loss of consciousness—Prednisone—ulcerative colitis	9.48e-05	0.00165	CcSEcCtD
Tolvaptan—AVPR2—Signaling by GPCR—CXCR2—ulcerative colitis	9.43e-05	0.00281	CbGpPWpGaD
Tolvaptan—Body temperature increased—Hydrocortisone—ulcerative colitis	9.36e-05	0.00162	CcSEcCtD
Tolvaptan—Feeling abnormal—Triamcinolone—ulcerative colitis	9.18e-05	0.00159	CcSEcCtD
Tolvaptan—Feeling abnormal—Methylprednisolone—ulcerative colitis	9.16e-05	0.00159	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	9.12e-05	0.00158	CcSEcCtD
Tolvaptan—Discomfort—Prednisone—ulcerative colitis	9.08e-05	0.00158	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—CCR6—ulcerative colitis	8.93e-05	0.00266	CbGpPWpGaD
Tolvaptan—Hypersensitivity—Prednisolone—ulcerative colitis	8.93e-05	0.00155	CcSEcCtD
Tolvaptan—AVPR2—Signaling by GPCR—CCR6—ulcerative colitis	8.87e-05	0.00265	CbGpPWpGaD
Tolvaptan—Body temperature increased—Triamcinolone—ulcerative colitis	8.81e-05	0.00153	CcSEcCtD
Tolvaptan—Anaphylactic shock—Prednisone—ulcerative colitis	8.81e-05	0.00153	CcSEcCtD
Tolvaptan—Decreased appetite—Dexamethasone—ulcerative colitis	8.79e-05	0.00153	CcSEcCtD
Tolvaptan—Decreased appetite—Betamethasone—ulcerative colitis	8.79e-05	0.00153	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	8.73e-05	0.00152	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Betamethasone—ulcerative colitis	8.73e-05	0.00152	CcSEcCtD
Tolvaptan—Hypersensitivity—Hydrocortisone—ulcerative colitis	8.72e-05	0.00151	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—SEL1L—ulcerative colitis	8.71e-05	0.0026	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	8.68e-05	0.00259	CbGpPWpGaD
Tolvaptan—Shock—Prednisone—ulcerative colitis	8.66e-05	0.0015	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—PTGER4—ulcerative colitis	8.66e-05	0.00258	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SEL1L—ulcerative colitis	8.65e-05	0.00258	CbGpPWpGaD
Tolvaptan—Nervous system disorder—Prednisone—ulcerative colitis	8.64e-05	0.0015	CcSEcCtD
Tolvaptan—AVPR2—GPCR downstream signaling—PTGER4—ulcerative colitis	8.6e-05	0.00256	CbGpPWpGaD
Tolvaptan—Skin disorder—Prednisone—ulcerative colitis	8.55e-05	0.00149	CcSEcCtD
Tolvaptan—Asthenia—Hydrocortisone—ulcerative colitis	8.49e-05	0.00147	CcSEcCtD
Tolvaptan—Anorexia—Prednisone—ulcerative colitis	8.39e-05	0.00146	CcSEcCtD
Tolvaptan—Pruritus—Hydrocortisone—ulcerative colitis	8.37e-05	0.00145	CcSEcCtD
Tolvaptan—Feeling abnormal—Betamethasone—ulcerative colitis	8.33e-05	0.00145	CcSEcCtD
Tolvaptan—Feeling abnormal—Dexamethasone—ulcerative colitis	8.33e-05	0.00145	CcSEcCtD
Tolvaptan—Hypersensitivity—Triamcinolone—ulcerative colitis	8.21e-05	0.00143	CcSEcCtD
Tolvaptan—Hypersensitivity—Methylprednisolone—ulcerative colitis	8.19e-05	0.00142	CcSEcCtD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	8.12e-05	0.00242	CbGpPWpGaD
Tolvaptan—Diarrhoea—Hydrocortisone—ulcerative colitis	8.1e-05	0.00141	CcSEcCtD
Tolvaptan—Dizziness—Prednisolone—ulcerative colitis	8.01e-05	0.00139	CcSEcCtD
Tolvaptan—Asthenia—Triamcinolone—ulcerative colitis	8e-05	0.00139	CcSEcCtD
Tolvaptan—Body temperature increased—Dexamethasone—ulcerative colitis	7.99e-05	0.00139	CcSEcCtD
Tolvaptan—Body temperature increased—Betamethasone—ulcerative colitis	7.99e-05	0.00139	CcSEcCtD
Tolvaptan—Asthenia—Methylprednisolone—ulcerative colitis	7.98e-05	0.00139	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—GHRL—ulcerative colitis	7.93e-05	0.00237	CbGpPWpGaD
Tolvaptan—Pruritus—Triamcinolone—ulcerative colitis	7.88e-05	0.00137	CcSEcCtD
Tolvaptan—AVPR2—GPCR downstream signaling—GHRL—ulcerative colitis	7.87e-05	0.00235	CbGpPWpGaD
Tolvaptan—Pruritus—Methylprednisolone—ulcerative colitis	7.87e-05	0.00137	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—PTGER4—ulcerative colitis	7.87e-05	0.00235	CbGpPWpGaD
Tolvaptan—Dizziness—Hydrocortisone—ulcerative colitis	7.83e-05	0.00136	CcSEcCtD
Tolvaptan—AVPR2—Signaling by GPCR—PTGER4—ulcerative colitis	7.81e-05	0.00233	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL10—ulcerative colitis	7.67e-05	0.00229	CbGpPWpGaD
Tolvaptan—Decreased appetite—Prednisone—ulcerative colitis	7.65e-05	0.00133	CcSEcCtD
Tolvaptan—Diarrhoea—Methylprednisolone—ulcerative colitis	7.61e-05	0.00132	CcSEcCtD
Tolvaptan—Headache—Prednisolone—ulcerative colitis	7.59e-05	0.00132	CcSEcCtD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	7.58e-05	0.00226	CbGpPWpGaD
Tolvaptan—Constipation—Prednisone—ulcerative colitis	7.53e-05	0.00131	CcSEcCtD
Tolvaptan—Headache—Hydrocortisone—ulcerative colitis	7.41e-05	0.00129	CcSEcCtD
Tolvaptan—Dizziness—Triamcinolone—ulcerative colitis	7.37e-05	0.00128	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	7.37e-05	0.0022	CbGpPWpGaD
Tolvaptan—Dizziness—Methylprednisolone—ulcerative colitis	7.35e-05	0.00128	CcSEcCtD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	7.32e-05	0.00218	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	7.31e-05	0.00218	CbGpPWpGaD
Tolvaptan—Feeling abnormal—Prednisone—ulcerative colitis	7.26e-05	0.00126	CcSEcCtD
Tolvaptan—Asthenia—Betamethasone—ulcerative colitis	7.25e-05	0.00126	CcSEcCtD
Tolvaptan—Asthenia—Dexamethasone—ulcerative colitis	7.25e-05	0.00126	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—GHRL—ulcerative colitis	7.2e-05	0.00215	CbGpPWpGaD
Tolvaptan—Nausea—Prednisolone—ulcerative colitis	7.2e-05	0.00125	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—CXCR1—ulcerative colitis	7.17e-05	0.00214	CbGpPWpGaD
Tolvaptan—Pruritus—Betamethasone—ulcerative colitis	7.15e-05	0.00124	CcSEcCtD
Tolvaptan—Pruritus—Dexamethasone—ulcerative colitis	7.15e-05	0.00124	CcSEcCtD
Tolvaptan—AVPR2—Signaling by GPCR—GHRL—ulcerative colitis	7.15e-05	0.00213	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCR1—ulcerative colitis	7.12e-05	0.00212	CbGpPWpGaD
Tolvaptan—Nausea—Hydrocortisone—ulcerative colitis	7.03e-05	0.00122	CcSEcCtD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	7.02e-05	0.00209	CbGpPWpGaD
Tolvaptan—Headache—Triamcinolone—ulcerative colitis	6.98e-05	0.00121	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—CALM3—ulcerative colitis	6.97e-05	0.00208	CbGpPWpGaD
Tolvaptan—Headache—Methylprednisolone—ulcerative colitis	6.97e-05	0.00121	CcSEcCtD
Tolvaptan—Body temperature increased—Prednisone—ulcerative colitis	6.96e-05	0.00121	CcSEcCtD
Tolvaptan—AVPR2—Signaling by GPCR—CALM3—ulcerative colitis	6.92e-05	0.00207	CbGpPWpGaD
Tolvaptan—Diarrhoea—Betamethasone—ulcerative colitis	6.92e-05	0.0012	CcSEcCtD
Tolvaptan—Diarrhoea—Dexamethasone—ulcerative colitis	6.92e-05	0.0012	CcSEcCtD
Tolvaptan—Dizziness—Dexamethasone—ulcerative colitis	6.69e-05	0.00116	CcSEcCtD
Tolvaptan—Dizziness—Betamethasone—ulcerative colitis	6.69e-05	0.00116	CcSEcCtD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	6.64e-05	0.00198	CbGpPWpGaD
Tolvaptan—Nausea—Triamcinolone—ulcerative colitis	6.62e-05	0.00115	CcSEcCtD
Tolvaptan—Nausea—Methylprednisolone—ulcerative colitis	6.6e-05	0.00115	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—ADRB2—ulcerative colitis	6.56e-05	0.00196	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—ADRB2—ulcerative colitis	6.52e-05	0.00194	CbGpPWpGaD
Tolvaptan—Hypersensitivity—Prednisone—ulcerative colitis	6.49e-05	0.00113	CcSEcCtD
Tolvaptan—Headache—Betamethasone—ulcerative colitis	6.33e-05	0.0011	CcSEcCtD
Tolvaptan—Headache—Dexamethasone—ulcerative colitis	6.33e-05	0.0011	CcSEcCtD
Tolvaptan—Asthenia—Prednisone—ulcerative colitis	6.32e-05	0.0011	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—CCL20—ulcerative colitis	6.3e-05	0.00188	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL20—ulcerative colitis	6.25e-05	0.00186	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	6.24e-05	0.00186	CbGpPWpGaD
Tolvaptan—Pruritus—Prednisone—ulcerative colitis	6.23e-05	0.00108	CcSEcCtD
Tolvaptan—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	6.17e-05	0.00184	CbGpPWpGaD
Tolvaptan—Diarrhoea—Prednisone—ulcerative colitis	6.02e-05	0.00105	CcSEcCtD
Tolvaptan—Nausea—Dexamethasone—ulcerative colitis	6.01e-05	0.00104	CcSEcCtD
Tolvaptan—Nausea—Betamethasone—ulcerative colitis	6.01e-05	0.00104	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—ADRB2—ulcerative colitis	5.96e-05	0.00178	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GNA12—ulcerative colitis	5.92e-05	0.00177	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—ADRB2—ulcerative colitis	5.92e-05	0.00177	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GNA12—ulcerative colitis	5.88e-05	0.00175	CbGpPWpGaD
Tolvaptan—Dizziness—Prednisone—ulcerative colitis	5.82e-05	0.00101	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—CXCR2—ulcerative colitis	5.61e-05	0.00167	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CXCL8—ulcerative colitis	5.61e-05	0.00167	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	5.59e-05	0.00167	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCR2—ulcerative colitis	5.57e-05	0.00166	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—ADCY5—ulcerative colitis	5.57e-05	0.00166	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CXCL8—ulcerative colitis	5.57e-05	0.00166	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—ADCY5—ulcerative colitis	5.53e-05	0.00165	CbGpPWpGaD
Tolvaptan—Headache—Prednisone—ulcerative colitis	5.52e-05	0.000958	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—CCR6—ulcerative colitis	5.28e-05	0.00157	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCR6—ulcerative colitis	5.24e-05	0.00156	CbGpPWpGaD
Tolvaptan—Nausea—Prednisone—ulcerative colitis	5.23e-05	0.000908	CcSEcCtD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—ALB—ulcerative colitis	5.08e-05	0.00152	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—ADCY5—ulcerative colitis	5.06e-05	0.00151	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—ADCY5—ulcerative colitis	5.02e-05	0.0015	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAML2—ulcerative colitis	5e-05	0.00149	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAML2—ulcerative colitis	4.97e-05	0.00148	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PTGER4—ulcerative colitis	4.65e-05	0.00139	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PTGER4—ulcerative colitis	4.61e-05	0.00138	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	4.51e-05	0.00134	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	4.32e-05	0.00129	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	4.32e-05	0.00129	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GHRL—ulcerative colitis	4.25e-05	0.00127	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GHRL—ulcerative colitis	4.22e-05	0.00126	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	4.19e-05	0.00125	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CALM3—ulcerative colitis	4.12e-05	0.00123	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CALM3—ulcerative colitis	4.09e-05	0.00122	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RIPK2—ulcerative colitis	4.06e-05	0.00121	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RIPK2—ulcerative colitis	4.03e-05	0.0012	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	4.02e-05	0.0012	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL2—ulcerative colitis	4.01e-05	0.00119	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	3.73e-05	0.00111	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ADRB2—ulcerative colitis	3.52e-05	0.00105	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ADRB2—ulcerative colitis	3.5e-05	0.00104	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—JAK2—ulcerative colitis	3.47e-05	0.00104	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—JAK2—ulcerative colitis	3.45e-05	0.00103	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CXCL8—ulcerative colitis	3.17e-05	0.000946	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—JAK2—ulcerative colitis	3.15e-05	0.000941	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CXCL8—ulcerative colitis	3.15e-05	0.000939	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—JAK2—ulcerative colitis	3.13e-05	0.000934	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	3.12e-05	0.000932	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—IL2—ulcerative colitis	3.03e-05	0.000904	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—IL2—ulcerative colitis	3.01e-05	0.000897	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ADCY5—ulcerative colitis	2.99e-05	0.000891	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ADCY5—ulcerative colitis	2.97e-05	0.000885	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TNF—ulcerative colitis	2.92e-05	0.00087	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CXCL8—ulcerative colitis	2.88e-05	0.000859	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CXCL8—ulcerative colitis	2.86e-05	0.000852	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL2—ulcerative colitis	2.75e-05	0.000821	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL2—ulcerative colitis	2.73e-05	0.000815	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.69e-05	0.000802	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CHP1—ulcerative colitis	2.48e-05	0.00074	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—DLD—ulcerative colitis	2.14e-05	0.000638	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	2.13e-05	0.000636	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—JAK2—ulcerative colitis	1.86e-05	0.000556	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.85e-05	0.000552	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—JAK2—ulcerative colitis	1.85e-05	0.000552	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RELA—ulcerative colitis	1.8e-05	0.000538	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RELA—ulcerative colitis	1.79e-05	0.000534	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCL8—ulcerative colitis	1.7e-05	0.000507	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL8—ulcerative colitis	1.69e-05	0.000504	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL2—ulcerative colitis	1.63e-05	0.000485	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6—ulcerative colitis	1.62e-05	0.000482	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL2—ulcerative colitis	1.61e-05	0.000481	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6—ulcerative colitis	1.61e-05	0.000479	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.54e-05	0.00046	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MMP9—ulcerative colitis	1.54e-05	0.000459	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.53e-05	0.000456	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MMP9—ulcerative colitis	1.53e-05	0.000455	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NFKB1—ulcerative colitis	1.52e-05	0.000454	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NFKB1—ulcerative colitis	1.51e-05	0.000451	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.44e-05	0.00043	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.44e-05	0.000429	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—STAT3—ulcerative colitis	1.37e-05	0.000408	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—STAT3—ulcerative colitis	1.36e-05	0.000405	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—DLD—ulcerative colitis	1.32e-05	0.000393	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.27e-05	0.000379	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TGFB1—ulcerative colitis	1.27e-05	0.000378	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TGFB1—ulcerative colitis	1.26e-05	0.000375	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TP53—ulcerative colitis	1.04e-05	0.000311	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TP53—ulcerative colitis	1.04e-05	0.000309	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS1—ulcerative colitis	1.03e-05	0.000309	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	9.68e-06	0.000289	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6—ulcerative colitis	9.55e-06	0.000285	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6—ulcerative colitis	9.48e-06	0.000283	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CALM3—ulcerative colitis	9.32e-06	0.000278	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ADCY5—ulcerative colitis	6.76e-06	0.000202	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS1—ulcerative colitis	6.38e-06	0.00019	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CALM3—ulcerative colitis	5.74e-06	0.000171	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARG—ulcerative colitis	5.04e-06	0.00015	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALB—ulcerative colitis	4.53e-06	0.000135	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCB1—ulcerative colitis	4.46e-06	0.000133	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ADCY5—ulcerative colitis	4.16e-06	0.000124	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS2—ulcerative colitis	3.97e-06	0.000118	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARG—ulcerative colitis	3.11e-06	9.26e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALB—ulcerative colitis	2.79e-06	8.33e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS2—ulcerative colitis	2.44e-06	7.29e-05	CbGpPWpGaD
